The industry priced $540.6 million of IPO paper last week, helped by the rebound in the sector and solid earnings from the big cap companies. While last month's proclamation of the mapping of the human genome may have helped, banker George Millstein of Pacific Growth Equities said, "the strong IPO market is related to the overall performance of the industry. A lot of stocks have rebounded from their lows, IPOs and follow-ons are performing very well and all of those contribute to a renewed interest in IPOs."